Community epidemiology of Chlamydia and Mycoplasma pneumoniae in LRTI in France over 29 months
- 115 Downloads
Background: The role of Chlamydia pneumoniae (CP) and Mycoplasma pneumoniae (MP) in lower respiratory tract infections (LRTI) is still little known in community settings. Methods: In all, 3207 adult cases of LRTI (871 with pneumonia, and 2336 with acute bronchitis) were prospectively included in the ETIIC1ETIIC : ETude de l’Incidence des Infections respiratoires basses d’origine Communautaire dues à Chlamydia pneumoniae et Mycoplasma pneumoniae (Incidence of CP and MP in LRTI in community settings)program by 303 general practitioners and 24 hospital physicians in France between September 1997 and February 2000. The polymerase chain reaction and immunoassays were used to detect CP or MP in 3198 pharyngeal specimens obtained by gargling. Results: Of these 3198 patients, 232 (7.3%), were PCR-positive for CP and/or MP. Immunoassays were far less sensitive than PCRs (Se = 2 and 13% for MP and CP). Among the 2336 patients with acute bronchitis, PCR was positive for CP in 95 (4.1%), and for MP, in 54 (2.3%). Among the 671 patients with radiologically confirmed pneumonia, PCR was positive for CP in 23 (3.4%), and for MP in 49 (7.3%). CP and MP displayed significant geographic heterogeneity. Independent clinical determinants of positive PCR for CP and/or MP were age below 45 years, previous antimicrobial therapy (especially betalactams). Clinical signs were not of practical use in distinguishing accurately between etiologic diagnoses. Conclusions: CP or MP diagnosed by PCR were found in more than 7% of patients with LRTI in community settings with a significant geographical heterogeneity and significant temporal trends in the incidence.
Key wordsAcute bronchitis Atypical bacteria Chlamydia pneumoniae Community-acquired pneumonia Mycoplasma pneumoniae
Unable to display preview. Download preview PDF.
- 2.Cook, P, Honeybourne, D 1994Review: Chlamydia pneumoniaeJ Antimicrob Chemotherapy34859873Google Scholar
- 3.Thom D, Grayston T. Infections with Chlamydia pneumoniae strain TWAR. Clin Chest Med 1991; 12: 245--256. (Review)Google Scholar
- 4.Dowell SF, Peeling RW, Boman J, et al. Standardizing Chlamydia pneumoniae assays : recommendations from the Centers for disease control and prevention (USA) and the laboratory centre for disease control (Canada). Clin Infect Dis 2001; 33: 492--503Google Scholar
- 7.Cunningham A, Johnston S, Julious S, Sillis M, Ward ME. The role of Chlamydia pneumoniae and other pathogens in acute episodes of asthma in children In: Orfila J, Byrne GI, Chernesky MA, Grayston JT, Jones RB, Ridgway GL, Saikku P, Schachter J, Stamm WE, Stephens RS. (eds), Chlamydial Infections, Proceedings of the 8th International Symposium on Human Chlamydial Infections. Esculapio, Bologna, Italy, 1994: 480--483Google Scholar
- 11.Falck G, Heyman L, Gnarpe J, Gnarpe H. Chlamydia pneumoniae. A common agent in acute bronchitis. Scand J Infect Dis 1994; 26: 179--187Google Scholar
- 12.Örtqvist A. Chlamydia pneumoniae (TWAR): A common agent in acute bronchitis. Scand J Infect Dis 1994; 26: 779--780Google Scholar
- 19.The Nordic Atypical Pneumonia Study Group. Atypical pneumonia in the Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline. J Antimicrob Chemother 1997; 39: 499--508Google Scholar
- 34.Layani-Milon, MP, Gras, I, et al. 1999Incidence of Upper Respiratory Tract Mycoplasama pneumoniae among outpatients in Rhône Alpes during five successive winter periodsJ clin Microb3617211726Google Scholar
- 35.Gnarpe, J, Lundback, A, Gnarpe, H, Sundelof, B 1997Comparison of nasopharyngeal and throat swabs for the detection of Chlamydia pneumoniae and Mycoplasma pneumoniae by polymerase chain reactionScand J Infect Dis1041112Google Scholar